9th Annual IBA World Life Sciences Conference
31 May - 2 Jun 2023
Session information
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
Intellectual Property and Entertainment Law Committee
(Lead)
Technology Law Committee
(Lead)
Description
Topic one
Post-Covid-19 litigation trends
Moderators
James C Fraser Thompson Hine, Washington, DC
Beth Weinman Ropes & Gray, Washington, DC
Topic two
Responsibility, liability and conflict of interests: risks met by compliance officers
Moderators
Catherine Longeval Van Bael & Bellis, Brussels
Emily Mason Amgen, Los Angeles, California
Topic three
Evolution of product liability rules
Moderators
Eric Alexander Reed Smith, Washington, DC
Edona Vila Borden Ladner Gervais, Toronto, Ontario
Topic four
Evolution of telemedicine (survey conducted by the IBA Healthcare and Life Sciences Committee)
Moderators
Renata Fialho Veirano, São Paulo
René Quashie Vice President, Digital Health, Consumer Technology Association, producer of CES®, Washington, DC
Topic five
Rare diseases and the continuous challenge of marketing an orphan drug
Moderators
David Parsons Leadiant Biosciences, Washington, DC
Kristin Wall Norton Rose, Toronto, Ontario
Topic six
Current opportunities and challenges in strategic collaborations
Moderators
Harry Rubin Kramer Levin, New York
Elysangela De Oliveria Rabelo Maurer Rabelo Maurer, Brazil
Topic seven
The European unitary patent court system
Moderators
Christophe Ronse Altius, Brussels
Amrish Tiwari KNS Partners, Gurgaon, Haryana
Topic eight
Post public health emergency
Moderator
Howard Sklamberg Arnold & Porter, Washington, DC
Topic nine
Patents in the US versus ROW
Moderators
Jason Jardine Knobbe Martens, San Diego, California
Alex Spiegler ArentFox Schiff, New York
Topic ten
Impact of metaverse on life sciences industry: fiction or future reality?
Moderators
Jeff Costellia Nixon Peabody, Washington, DC
Elisa Stefanini Portolano Cavallo, Milan
Topic eleven
Recent regulatory changes and opportunities in medical and recreational cannabis
Moderators
Ignacio Gillmore Carey, Santiago
Mariana Larrea Grupo Libera, Mexico City
Topic twelve
Public to private sector technology transfer: challenges and solutions
Moderator
Camila Parise Pinheiro Neto, São Paulo
Topic thirteen
Food labelling (octagons, symbols, difficulties) and cannabis regulations
Moderators
Ana Maria Castro Lloreda Camacho, Bogota
Viviana Cervieri Cervieri Monsuárez, Montevido
Topic fourteen
Managing market access at a global level
Moderators
Markus Schott Bär & Karrer, Zurich
Charlotte Tillett Stevens & Bolton, Guildford, Surrey, England
Topic fifteen
Pricing of medications
Moderators
Miranda Franco Holland & Knight, Washington, DC
Andreas Wildi Walder Wyss, Zurich
Topic sixteen
Abortion pill: medicine versus law
Moderators
John Murphy Chief Policy Officer, Biotechnology Innovation Organization, Washington, DC
Eva Temkin King & Spalding, Washington, DC
Topic seventeen
How new players will impact traditional healthcare providers
Moderator
Gary Copelovitz Lipa Meir & Co, Tel Aviv
Session / Workshop Chair(s)
| Eric Lawrence Alexander | Reed Smith LLP, Washington, District of Columbia, USA |
| Ana Maria Castro | Lloreda Camacho & Co, Bogota, Colombia |
| Viviana Cervieri | Cervieri Monsuárez, Montevideo, Uruguay |
| Gary Copelovitz | Lipa Meir & Co, Tel Aviv, Israel |
| Jeffrey Costellia | Nixon Peabody LLP, Washington, District of Columbia, USA; Website Officer, Intellectual Property and Entertainment Law Committee |
| Renata Fialho | Veirano Advogados, São Paulo, Brazil; Latin American Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee |
| Miranda Franco | Holland & Knight, Washington, District of Columbia, USA |
| James C Fraser | Thompson Hine, Washington, District of Columbia, USA |
| Ignacio Gillmore | Carey y Cia, Santiago, Chile |
| Yuval Horn | Horn & Co, Tel Aviv, Israel; Member, Technology Law Committee Advisory Board |
| Jason Jardine | Knobbe Martens, San Diego, California, USA; Chair, Patent Law Subcommittee |
| Mariana Larrea | MLA Consulting / Legal Boutique, Toluca, Mexico |
| Catherine Longeval | Van Bael & Bellis, Brussels, Belgium; Co-Chair, Healthcare and Life Sciences Law Committee |
| Emily Mason | Amgen, Thousand Oaks, California, USA |
| John Murphy III | Biotechnology Innovation Organization, Washington, District of Columbia, USA |
| Camila Martino Parise | Pinheiro Neto Advogados, São Paulo, Brazil |
| David Parsons | Leadiant Biosciences, Washington, District of Columbia, USA |
| René Quashie | Consumer Technology Association, Arlington, Virginia, USA |
| Elysangela Rabelo | Rabelo Maurer Advocacia, São Paulo, Brazil; Vice Chair, Life Sciences Subcommittee |
| Christophe Ronse | Altius, Brussels, Belgium; Scholarship Officer, Intellectual Property and Entertainment Law Committee |
| Harry Rubin | Kramer Levin, New York, New York, USA |
| Markus Schott | Baer & Karrer, Zürich, Switzerland |
| Howard Sklamberg | Arnold & Porter, Washington, District of Columbia, USA |
| Alex Spiegler | Arent Fox Schiff LLP, New York, New York, USA |
| Elisa Stefanini | Portolano Cavallo, Rome, Italy |
| Eva Temkin | King & Spalding, Washington, District of Columbia, USA |
| Charlotte Tillett | Stevens & Bolton, Guildford, England |
| Amrish Tiwari | K&S Partners, New Delhi, Delhi, India; Chair, Life Sciences Subcommittee |
| Edona Vila | Borden Ladner Gervais, Toronto, Ontario, Canada; Membership Officer, Product Law and Advertising Committee |
| Kristin Wall | Norton Rose Fulbright, Toronto, Ontario, Canada |
| Beth Weinman | Ropes & Gray, Washington, District of Columbia, USA |
| Andreas Wildi | Walder Wyss Ltd, Bern, Switzerland |